Ren Lin
Impact in
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Mesenchymal stem cell research
Papers in
- Hematology 44
- Hematopoietic Stem Cell Transplantation 32
- Acute Myeloid Leukemia Research 12
-
- Acute Lymphoblastic Leukemia research 13
- Co-authors
- Qifa Liu (41 shared papers)Fen Huang (32 shared papers)Zhiping Fan (30 shared papers)Li Xuan (29 shared papers)Na Xu (25 shared papers)Yu Wang (9 shared papers)Jing Sun (29 shared papers)Xiao‐Jun Huang (6 shared papers)
- Journals
- Blood (7 papers)Journal of Hematology & Oncology (5 papers)Transplantation and Cellular Therapy (5 papers)Bone Marrow Transplantation (5 papers)BMC Medicine (3 papers)
- Partner nations
- ChinaUnited Kingdom
In The Last Decade
Ren Lin
58 papers receiving 1.5k citations
Ren Lin's Hit Papers
Peers
Comparison fields: 5 of 65
- Hematology 909
- Genetics 113
- Oncology 94
- Public Health, Environmental and Occupational Health 120
- Clinical Biochemistry 17
Countries citing papers authored by Ren Lin
This map shows the geographic impact of Ren Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ren Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ren Lin more than expected).
Fields of papers citing papers by Ren Lin
This network shows the impact of papers produced by Ren Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ren Lin. The network helps show where Ren Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ren Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial Hit paper breakdown → | 2020 | 258 |
| 2 | 2018 | 220 | |
| 3 | 2019 | 95 | |
| 4 | 2013 | 79 | |
| 5 | 2021 | 66 | |
| 6 | 2022 | 66 | |
| 7 | 2023 | 57 | |
| 8 | 2019 | 56 | |
| 9 | 2018 | 52 | |
| 10 | 2023 | 51 | |
| 11 | 2020 | 46 | |
| 12 | 2022 | 33 | |
| 13 | 2016 | 31 | |
| 14 | 2019 | 24 | |
| 15 | 2024 | 24 | |
| 16 | 2020 | 21 | |
| 17 | 2021 | 20 | |
| 18 | 2023 | 20 | |
| 19 | 2014 | 18 | |
| 20 | 2023 | 18 |
About Ren Lin
Ren Lin is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Clinical Biochemistry, Oncology and Epidemiology, having authored 66 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (32 papers), Acute Lymphoblastic Leukemia research (13 papers), Acute Myeloid Leukemia Research (12 papers), Cytomegalovirus and herpesvirus research (4 papers), Bacterial Identification and Susceptibility Testing (3 papers), Antifungal resistance and susceptibility (2 papers), Mesenchymal stem cell research (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Hematology (909 citations), Genetics (113 citations), Oncology (94 citations), Public Health, Environmental and Occupational Health (120 citations) and Clinical Biochemistry (17 citations). Ren Lin has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Qifa Liu, Fen Huang, Zhiping Fan, Li Xuan, Na Xu, Yu Wang, Jing Sun, Xiao‐Jun Huang, Ting Yang and Andy Peng Xiang. Their work appears in journals such as Blood, Journal of Hematology & Oncology, Transplantation and Cellular Therapy, Bone Marrow Transplantation and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.